2016

  • M.F. Miah, G. Conseil, and S.P.C. Cole. N-glycans do not affect plasma membrane localization of multidrug resistance protein 4 (MRP4) but selectively alter its prostaglandin E2 transport activity.  Biochem. Biophys. Res. Commun. 469:954-959 (2016).
  • M.A. Csandl, G. Conseil, and S.P.C. Cole. Cysteinyl leukotriene receptor 1/2 antagonists nonselectively modulate organic anion transport by multidrug resistance proteins (MRP1-4).  Drug Metab. Disp. 44: 857-866 (2016).
  • Y. Huang, S.P.C. Cole, T. Cai and Y. Cai. Applications of nanoparticle delivery systems for the reversal of multidrug resistance in cancer.  Oncol. Lett. OL-7589-144233 (2016).
  • C. B. Shukalek, D.P. Swanlund, R.K. Rousseau, K.E. Weigl, S.P.C. Cole and E.M. Leslie.  Arsenic triglutathione [As(GS)3] transport by multidrug resistance protein 1 (MRP1/ABCC1) is selectively modulated by phosphorylation of Tyr920/Ser921 and glycosylation of Asn19/Asn23.  Molec. Pharmacol. 90: 127-139 (2016). PMID: 27297967
  • M. Banerjee, V. Marensi, G. Conseil, X.C. Le, S.P.C. Cole and E.M. Leslie. Polymorphic variants of MRP4/ABCC4 differentially modulate the transport of methylated arsenic metabolites and physiological organic anions. Biochem. Pharmacol. 120:72-82 (2016).  PMID: 27659809